Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment

被引：4
|
作者：
Magge, Tara [1 ]
Shaikh, Hira [2 ]
Chaudhary, Rekha [2 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA
[2] Univ Cincinnati, Dept Hematol & Oncol, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2022年 / 29卷 / 06期
关键词：
PHASE-III; CHEMOTHERAPY; SURVIVAL; INHIBITORS; NIVOLUMAB; RATES;
D O I：
10.1097/MJT.0000000000001186
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E767 / E769
页数：3
相关论文
共 50 条
  • [31] Evaluation of prognostic factors in lung cancers with surgical complete response after induction treatment
    Dogru, Mustafa Vedat
    Sezen, Celal Bugra
    Aker, Cemal
    Erdogu, Volkan
    Saydam, Ozkan
    Olcmen, Aysun
    Cansever, Levent
    Metin, Muzaffer
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 29 (02): : 201 - 211
  • [32] Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab
    Glazar, Daniel J.
    Johnson, Matthew
    Farinhas, Joaquim
    Steuer, Conor E.
    Saba, Nabil F.
    Bonomi, Marcelo
    Chung, Christine H.
    Enderling, Heiko
    ORAL ONCOLOGY, 2022, 127
  • [33] QUANTIFYING THE BENEFIT OF A PATHOLOGIC COMPLETE RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER
    Scheer, Richard V.
    Fakiris, Achilles J.
    Johnstone, Peter A. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 996 - 1001
  • [34] An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting
    Athanassios P. Kyritsis
    Victor A. Levin
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 971 - 983
  • [35] An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting
    Kyritsis, Athanassios P.
    Levin, Victor A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 971 - 983
  • [36] Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
    Vera Aguilera, Jesus
    Paludo, Jonas
    McWilliams, Robert R.
    Zhang, Henan
    Li, Ying
    Kumar, Anagha B.
    Failing, Jarrett
    Kottschade, Lisa A.
    Block, Matthew S.
    Markovic, Svetomir N.
    Dong, Haidong
    Dronca, Roxana S.
    Yan, Yiyi
    MELANOMA RESEARCH, 2020, 30 (04) : 364 - 375
  • [37] Fatal gastrointestinal toxicity with ipilimumab after BRAF/MEK inhibitor combination in a melanoma patient achieving pathological complete response
    Gonzalez-Cao, Maria
    Boada, Aram
    Teixido, Cristina
    Fernandez-Figueras, Maria Teresa
    Mayo, Clara
    Tresserra, Francesc
    Bustamante, Jean
    Viteri, Santiago
    Puertas, Enrique
    Santarpia, Mariacarmela
    Riso, Aldo
    Barron, Feliciano
    Karachaliou, Niki
    Rosell, Rafael
    ONCOTARGET, 2016, 7 (35) : 56619 - 56627
  • [38] Clinical Significance of Pathological Complete Response in Patients with Metastatic Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment - Lessons Learned
    Cheng, Chi-Tung
    Tsai, Chun-Yi
    Yeh, Chun-Nan
    Chiang, Kun-Chun
    Chen, Yen-Yang
    Wang, Shang-Yu
    Chen, Tsung-Wen
    Tseng, Jeng-Hwei
    Jung, Shih-Ming
    Chen, Tse-Ching
    Yeh, Ta-Sen
    ANTICANCER RESEARCH, 2014, 34 (11) : 6617 - 6625
  • [39] Metastatic renal cancer: evolution of five complete response cases after the antiangiogenic discontinuation
    Demiselle, Julien
    Lheureux, Stephanie
    Clarisse, Benedicte
    Sevin, Emmanuel
    Joly, Florence
    BULLETIN DU CANCER, 2011, 98 (06) : 626 - 632
  • [40] Prognosis for Metastatic Colorectal Cancer Patients Achieving Complete Response After Systemic Chemotherapy
    Manabe, Takahiro
    Takii, Yasumasa
    Oyanagi, Hidehito
    Nogami, Hitoshi
    Maruyama, Satoshi
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 501 - 505
12345